Tissue Analytics, Inc. — Form D
Tissue Analytics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-23. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-01-23
- Form: D
- Accession: 0001633370-18-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 12
- Date of first sale: 2018-01-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303910
Issuer
- Name: Tissue Analytics, Inc.
- CIK: 0001633370
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3 SOUTH FREDERICK STREET, BALTIMORE, MD, 21202
- Phone: 781-789-0229
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Joshua Budman | Director | Baltimore, MD |
| Karen Griffith Gryga | Director | Baltimore, MD |
| Kevin Keenahan | Director | Baltimore, MD |
| David Kim | Director | Los Angeles, CA |
| Kevin Keenahan | Executive Officer | Baltimore, MD |
| Joshua Budman | Executive Officer | Baltimore, MD |
| Gabriel Brat | Director | Brookline, MA |
Other filings by this issuer (3)
More